IRIS
GENNARI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.276
EU - Europa 10.701
AS - Asia 7.200
SA - Sud America 1.432
Continente sconosciuto - Info sul continente non disponibili 372
AF - Africa 236
OC - Oceania 31
Totale 35.248
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.048
CN - Cina 2.442
SG - Singapore 2.322
RU - Federazione Russa 2.082
IT - Italia 1.978
GB - Regno Unito 1.674
IE - Irlanda 1.518
BR - Brasile 1.202
UA - Ucraina 884
FR - Francia 688
VN - Vietnam 672
SE - Svezia 665
HK - Hong Kong 563
DE - Germania 525
KR - Corea 378
FI - Finlandia 341
IN - India 170
BD - Bangladesh 153
CA - Canada 116
ZA - Sudafrica 97
TR - Turchia 93
AR - Argentina 89
IQ - Iraq 70
NL - Olanda 67
ES - Italia 48
MX - Messico 47
PL - Polonia 45
ID - Indonesia 41
PK - Pakistan 40
JP - Giappone 34
CL - Cile 33
EC - Ecuador 32
NG - Nigeria 31
CZ - Repubblica Ceca 29
BE - Belgio 28
CO - Colombia 27
SA - Arabia Saudita 25
AT - Austria 24
UZ - Uzbekistan 24
KE - Kenya 22
AU - Australia 21
NP - Nepal 20
CI - Costa d'Avorio 19
LT - Lituania 18
VE - Venezuela 17
MY - Malesia 15
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
JM - Giamaica 13
JO - Giordania 13
MA - Marocco 13
IR - Iran 12
TN - Tunisia 12
EU - Europa 11
GR - Grecia 11
PE - Perù 11
DK - Danimarca 10
HU - Ungheria 10
IL - Israele 10
PH - Filippine 10
SY - Repubblica araba siriana 10
CR - Costa Rica 9
EG - Egitto 9
PY - Paraguay 9
UY - Uruguay 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
CH - Svizzera 7
ET - Etiopia 7
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
OM - Oman 7
TH - Thailandia 7
GE - Georgia 6
HN - Honduras 6
KG - Kirghizistan 6
LV - Lettonia 6
TT - Trinidad e Tobago 6
PT - Portogallo 5
RS - Serbia 5
AL - Albania 4
AM - Armenia 4
BB - Barbados 4
HR - Croazia 4
IM - Isola di Man 4
KH - Cambogia 4
BH - Bahrain 3
GT - Guatemala 3
LB - Libano 3
LU - Lussemburgo 3
NI - Nicaragua 3
PA - Panama 3
PR - Porto Rico 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
Totale 34.844
Salva come PNG Salva come JPEG
Città #
Dallas 2.630
Dublin 1.500
Fairfield 1.474
Southend 1.385
Singapore 1.210
Ashburn 1.126
Jacksonville 706
Chandler 702
Santa Clara 698
Woodbridge 657
Milan 590
Wilmington 562
Houston 558
Moscow 545
Hong Kong 542
Seattle 533
Cambridge 519
Beijing 510
Hefei 464
Council Bluffs 452
San Jose 408
Seoul 373
Princeton 314
Ann Arbor 300
The Dalles 250
Siena 225
Nanjing 216
Ho Chi Minh City 213
Rome 211
Los Angeles 197
Lauterbourg 188
Helsinki 157
Hanoi 136
Boardman 106
Buffalo 100
San Diego 100
Shanghai 99
New York 98
São Paulo 89
Nanchang 86
Columbus 85
Florence 81
Johannesburg 78
London 74
Dong Ket 72
Munich 65
Figino 63
Izmir 62
San Mateo 62
Shenyang 59
Redondo Beach 52
Tianjin 52
Dearborn 47
Orem 46
Bengaluru 45
Rio de Janeiro 42
Hebei 41
Turin 41
Belo Horizonte 40
Jiaxing 38
Brooklyn 37
Kunming 37
San Francisco 37
Warsaw 35
Changsha 34
Da Nang 33
Abuja 30
Chicago 30
Denver 30
Montreal 30
Tokyo 30
Toronto 30
Frankfurt am Main 29
Naples 28
Chennai 27
Atlanta 26
Boston 26
Brussels 26
Düsseldorf 26
Turku 26
Nuremberg 24
Redwood City 24
Brasília 23
Hangzhou 22
Lappeenranta 22
Manchester 22
Málaga 22
Norwalk 22
Tashkent 22
Baghdad 21
Bologna 21
Porto Alegre 21
Guangzhou 20
Haiphong 20
Jinan 20
Phoenix 20
Stockholm 20
Zhengzhou 20
Abidjan 19
Amsterdam 19
Totale 23.405
Salva come PNG Salva come JPEG
Nome #
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of type 2 diabetes mellitus: friends or foes to bone health? a narrative review of clinical studies 1.255
null 398
Activation of the Wnt pathway by small peptides: rational design, synthesis and biological evaluation 337
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 309
Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study 307
Falls, fractures and vitamin D: a never-ending story? 278
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone 276
Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women 268
Aromatase activity and bone homeostasis in men 260
Aromatase activity and bone loss in men 259
A non-synonymous TNFRSF11A variation increases NFkB activity and the severity of Paget's disease 259
Characteristics and familial aggregation of Paget's disease of bone in Italy 254
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. 249
The association of body composition and sexhormones with quantitative ultrasound parameters at the calcaneus and phalanxes in elderly women. 248
Bazedoxifene for the prevention of postmenopausal osteoporosis 247
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease 239
Age-related decline of bone mass and intestinal calcium absorption in normal males 239
Dual X-ray absorptiometry and bone ultrasonography in patients with Rett Syndrome 235
Undiagnosed vertebral fractures influence quality of life in postmenopausal women with reduced ultrasound parameters. 233
Absence of correlation between BMP-4 polymorphism and postmenopausal osteoporosis in Italian women 230
Endocrine actions of osteocalcin 230
The usefulness of quantitative ultrasound (QUS) measurements in the evaluation of skeletal status in newborns and in children 228
ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor 228
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. 225
Aromatase activity and bone loss 221
Bone metabolism in men: role of aromatase activity 219
Corretto uso dei marcatori del rimodellamento osseo 219
Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls 217
Update on the pathogenesis and genetics of Paget's disease of bone 216
Vitamin D receptor genotypes and intestinal calcium absorption in postmenopausal women 213
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget’s disease of bone 212
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone 209
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapy on bone metabolism 209
Mutation of PFN1 gene in an early onset, polyostotic Paget-like disease 209
Adiponectin may play a crucial role in the metabolic effects of GLP-1RAs treatment in patients with Type 2 Diabetes Mellitus: a preliminary longitudinal study 208
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women 208
Appropriate models for novel osteoporosis drug discovery and future perspectives 207
Longitudinal association between sex hormone levels, bone loss and bone turnover in elderly men. 204
Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function 202
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family 201
CALCITRIOLO E OSTEOPOROSI 199
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 198
Misdiagnosis of vertebral fractures on local radiographic readings of the multicentre POINT (Prevalence of Osteoporosis in INTernal medicine) study 198
Analysis of Usual Consumption of Vitamin D Among Adult Individuals in Italy 197
Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis 197
Effect of electromagnetic fields on bone mineral density and biochemical markers of bone turnover in osteoporosis: a single-blind, randomized pilot study 197
Evidence for increased clinical severity of familial and sporadic Paget’s disease of bone in Campania, southern Italy 196
The combined use of ultrasound and densitometry in the prediction of vertebral fracture 196
Apporto nutrizionale di vitamina D in Italia [Feeding and vitamin D in Italy] 195
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone 195
The effects of zoledronic acid on serum lipids in multiple myeloma patients 194
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene 194
Left ventricular hypertrophy differences in male professional runners and in young patients suffering from mild hypertension 193
Effect of electromagnetic fields on bone mineral density and biochemical markers of bone turnover in osteoporosis: a single-blind, randomized, pilot study 191
The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study 191
Glucagon-like Peptide-1 Receptor Agonists and Diabetic Osteopathy: Another Positive Effect of Incretines? A 12 Months Longitudinal Study 188
Bona fide genetic associations with bone mineral density 188
Diagnosis of Endocrine Disease: Evaluation of bone fragility in endocrine disorders. 188
Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease 187
Infection by CagA-Positive Helicobacter pylori Strains and Bone Fragility: A Prospective Cohort Study 187
Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density 185
Aromatase deficiency and male osteoporosis 185
Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis 185
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease 185
Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree 184
Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis 183
Dietary Vitamin D Intake in Italian Subjects: Validation of a Frequency Food Questionnaire (FFQ) 182
Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy 180
Bisphosphonates target B cells to enhance humoral immune responses 180
Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk 179
Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status. 178
Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells 177
Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men 176
Mechanisms of impaired bone strength in type 1 and 2 diabetes 176
Osteoporosis in men: pathophysiology and treatment 175
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone 175
Update on the pharmacogenetics of the vitamin D receptor and osteoporosis 174
Prevalence of Paget’s disease of bone in Italy 174
The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women 173
MicroRNAs in bone diseases 173
Quantitative ultrasound and bone mineral density in patients with primary hyperparathyroidism before and after surgical treatment 172
PTH in the pathogenesis and treatment of glucocorticoid-induced osteoporosis 172
Bone fragility in gastrointestinal disorders 171
Paget's disease of bone: epidemiology, pathogenesis and pharmacotherapy 171
Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women 171
Diagnosis and management of Paget's disease of bone in adults: a clinical guideline 171
Vitamin D Status in Paget Disease of Bone and Efficacy-Safety Profile of Cholecalciferol Treatment in Pagetic Patients with Hypovitaminosis D. 170
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 169
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis 168
Bone fragility in men: where are we? 168
Perspectives in the treatment and prevention of osteoporosis 168
Usefulness of bone quantitative ultrasound in management of osteoporosis in men 168
Idiopathic osteoporosis in men 167
Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders 166
Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma 166
FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women 165
Does calcium supplementation reduce the risk of osteoporotic fracture and bone loss? 164
Case report: an unusual case of acute lower limb ischemia as precursor of the asherson’s syndrome 164
Paget’s disease of bone in Italy. 163
CagA+ H. pylori Infection increases the risk of osteoporosis in men and is associated with decreased levels of estrogens in patients 163
Totale 21.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.027
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.815 0 280 83 202 69 55 87 69 125 224 177 444
2022/20232.674 184 175 355 388 289 584 55 196 270 47 93 38
2023/20242.280 230 76 217 72 52 533 738 44 18 57 46 197
2024/20255.010 105 267 368 238 607 284 170 291 443 278 492 1.467
2025/202612.787 987 1.803 2.249 1.298 1.859 481 1.174 311 399 674 448 1.104
2026/2027856 492 364 0 0 0 0 0 0 0 0 0 0
Totale 35.248